Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,537 | 4 | 69.2% |
| Grant | $630.00 | 1 | 12.3% |
| Travel and Lodging | $472.83 | 1 | 9.3% |
| Food and Beverage | $469.37 | 16 | 9.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $3,590 | 3 | $0 (2023) |
| Lilly USA, LLC | $630.00 | 1 | $0 (2017) |
| GE HEALTHCARE | $274.00 | 1 | $0 (2023) |
| Insulet Corporation | $169.49 | 8 | $0 (2024) |
| Vertex Pharmaceuticals Incorporated | $163.33 | 1 | $0 (2022) |
| ABBVIE INC. | $130.37 | 6 | $0 (2024) |
| Dexcom, Inc. | $112.50 | 1 | $0 (2018) |
| Sentynl Therapeutics, Inc. | $40.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $203.45 | 10 | Insulet Corporation ($169.49) |
| 2023 | $3,960 | 8 | PFIZER INC. ($3,590) |
| 2022 | $203.33 | 2 | Vertex Pharmaceuticals Incorporated ($163.33) |
| 2018 | $112.50 | 1 | Dexcom, Inc. ($112.50) |
| 2017 | $630.00 | 1 | Lilly USA, LLC ($630.00) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/22/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $4.29 | General |
| Category: Insulin Pump | ||||||
| 05/02/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $6.22 | General |
| Category: Insulin Pump | ||||||
| 04/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $8.11 | General |
| Category: Insulin Pump | ||||||
| 04/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $2.67 | General |
| Category: Insulin Pump | ||||||
| 04/04/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $6.33 | General |
| Category: Insulin Pump | ||||||
| 04/04/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $6.26 | General |
| Category: Insulin Pump | ||||||
| 03/21/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Insulin Pump | ||||||
| 03/01/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $10.61 | General |
| Category: Insulin Pump | ||||||
| 02/01/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/28/2023 | PFIZER INC. | NGENLA (Drug) | Consulting Fee | Cash or cash equivalent | $3,060.00 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 11/16/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/03/2023 | GE HEALTHCARE | — | Consulting Fee | Cash or cash equivalent | $274.00 | General |
| 10/22/2023 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $472.83 | General |
| 10/22/2023 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $57.01 | General |
| 09/08/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/02/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/07/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/31/2022 | Sentynl Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| 06/10/2022 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $163.33 | General |
| 05/10/2018 | Dexcom, Inc. | Dexcom CGM (Device) | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: Endocrinology | ||||||
| 07/18/2017 | Lilly USA, LLC | — | Grant | Cash or cash equivalent | $630.00 | General |
About Dr. Hariram Ganesh, M.D
Dr. Hariram Ganesh, M.D is a Pediatrics healthcare provider based in Roslyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2013. The National Provider Identifier (NPI) number assigned to this provider is 1982946174.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hariram Ganesh, M.D has received a total of $5,110 in payments from pharmaceutical and medical device companies, with $203.45 received in 2024. These payments were reported across 22 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($3,537).
Practice Information
- Specialty Pediatrics
- Location Roslyn, NY
- Active Since 03/26/2013
- Last Updated 03/26/2013
- Taxonomy Code 208000000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982946174
Products in Payments
- NGENLA (Drug) $3,060
- Omnipod (Device) $169.49
- LUPRON DEPOT (Drug) $130.37
- Dexcom CGM (Device) $112.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.